Tirzepatide activates two metabolic pathways simultaneously, making it potentially more effective but also newer with less long-term safety data
When Providers Recommend Micro-Dosing A GLP-1 provider may suggest micro-dosing when: Youve reached your goal weight You feel ready to lower medication Youre experiencing appetite fluctuations You want to transition off GLP-1 slowly Insurance or cost changes require a dosage shift You plateau but dont need full therapeutic dosing It is a middle path not quitting cold turkey, not staying on full dose
MNT spoke with Jeffrey Zarin, MD, an orthopedic surgeon specializing in joint replacement surgery at Cedars-Sinai Orthopaedics in Los Angeles, CA, about this study, who commented that his first reaction was to be cautious about over-interpreting its findings
On clinical examination, the patient had dry mouth, with minimal frothy saliva (Fig
TTFields are not the only non-invasive strategy gaining traction
Here are some compelling facts about allulose that make it a standout
